Lüers Claus, Edelmann Frank, Wachter Rolf, Pieske Burkert, Mende Meinhard, Angermann Christiane, Ertl Georg, Düngen Hans-Dirk, Störk Stefan
University of Oldenburg, European Medical School Oldenburg-Groningen, Germany.
Department of Cardiology and Pneumology, University of Göttingen, Germany.
Clin Cardiol. 2017 Sep;40(9):667-673. doi: 10.1002/clc.22710. Epub 2017 May 3.
We investigated the modifying role and prognostic importance of diastolic dysfunction (DD) in patients with heart failure and systolic dysfunction (SD).
The echocardiographic evaluation of diastolic function in patients with SD provides further prognostic information.
From the German Competence Network Heart Failure, 1046 heart failure patients with reduced left ventricular ejection fraction (LVEF; <50%) were echocardiographically studied and followed for a median of 5 years. SD was subdivided into nonsevere (LVEF 36%-49%) and severe (LVEF ≤35%); DD was subdivided into nonsevere (E/E' <15) and severe (E/E' ≥15).
In general, severe SD was associated with higher hazard ratios (HRs; 2-fold to 3.5-fold) for all endpoints (all-cause death, cardiac death, cardiovascular hospitalization, duration of hospitalization). Patients with severe SD had a 2.5-fold risk of death (95% confidence interval [CI]: 1.84-3.47, P < 0.001), and patients with severe DD showed a 1.8-fold risk (95% CI: 1.17-2.61, P = 0.004). Furthermore, we observed a strong interaction of SD and DD: concomitant severe DD in patients with moderate SD increased risk substantially (HR: 1.73, 95% CI: 1.16-2.6, P = 0.007); by contrast, in patients with severe SD, additional presence of severe DD added little or no risk (HR for interaction: 0.5-1.2).
In heart failure patients with reduced LVEF, the evaluation of diastolic function provides additional prognostic information. Although severe SD generally increased the risk for all endpoints, the degree of DD and its impact as a prognostic marker for overall and cardiovascular mortality appeared of particular relevance in subjects with nonsevere SD.
我们研究了舒张功能障碍(DD)在心力衰竭和收缩功能障碍(SD)患者中的调节作用及预后重要性。
对SD患者进行舒张功能的超声心动图评估可提供更多预后信息。
从德国心力衰竭能力网络中选取1046例左心室射血分数(LVEF;<50%)降低的心力衰竭患者进行超声心动图研究,并随访中位时间5年。SD分为非重度(LVEF 36%-49%)和重度(LVEF≤35%);DD分为非重度(E/E'<15)和重度(E/E'≥15)。
总体而言,重度SD与所有终点事件(全因死亡、心源性死亡、心血管住院、住院时长)的较高风险比(HR;2倍至3.5倍)相关。重度SD患者的死亡风险为2.5倍(95%置信区间[CI]:1.84-3.47,P<0.001),重度DD患者的风险为1.8倍(95%CI:1.17-2.61,P = 0.004)。此外,我们观察到SD和DD之间存在强烈的相互作用:中度SD患者伴有重度DD时,风险大幅增加(HR:1.73,95%CI:1.16-2.6,P = 0.007);相比之下,在重度SD患者中,额外存在重度DD增加的风险很小或没有增加(交互作用的HR:0.5-1.2)。
在LVEF降低的心力衰竭患者中,舒张功能评估可提供额外的预后信息。虽然重度SD通常会增加所有终点事件的风险,但DD的程度及其作为总体和心血管死亡率预后标志物的影响在非重度SD患者中似乎尤为重要。